Abstract
Visceral leishmaniasis (VL), caused by Leishmania infantum, is a severe systemic disease that poses a significant public health challenge. In the mammalian host, the parasite invades vital organs such as the spleen and liver, and current therapeutic options are limited. Resistance to pentavalent antimonials, one of the primary choise for treatment, is increasingly compromised by the emerg…